Skip to content

Dr. Sharon Peles

GI Medical Oncologist, Head of Gastrointestinal Cancer Service

Languages
  • עברית
  • Eng
  • Advanced training at Royal Marsden Hospital in London under Prof. Cunningham
Message on WhatsApp

We respond within 30 minutes

No reviews yet

About the Doctor

Dr. Sharon Peles is a medical oncologist specializing in gastrointestinal cancers. She leads the Gastrointestinal Cancer Service at the Oncology Division of Ichilov Medical Center in Tel Aviv.
Her clinical work focuses on complex and advanced gastrointestinal malignancies, including metastatic and recurrent disease. Dr. Peles is also involved in clinical research and applies modern systemic therapies tailored to each patient.
Dr. Peles works closely with multidisciplinary teams including surgical oncology, radiation oncology, and radiology specialists to determine the most appropriate treatment strategy for each patient.
Dr. Peles follows an individualized approach for each patient. Treatment decisions are based on tumor biology, stage of disease, and the patient’s overall condition.
Depending on the clinical situation, treatment may include:

  • Systemic therapy
  • Immunotherapy
  • Targeted therapy
  • Combination treatment
  • Clinical trials

Her goal is to develop a personalized and evidence-based treatment strategy.

Research and Publications

Dr. Peles is involved in clinical research in gastrointestinal cancers.

  • More than 10 scientific publications (PubMed)
  • Participation in international conferences
  • Clinical research activity

Areas of expertise

  • Colorectal cancer
  • Rectal cancer
  • Gastric cancer
  • Pancreatic cancer
  • Liver cancer
  • Biliary tract cancer
  • Esophageal cancer
  • Neuroendocrine tumors
  • Metastatic gastrointestinal cancers
  • Recurrent GI cancers
  • Immunotherapy
  • Targeted therapy
  • Chemotherapy
  • Personalized oncology
  • Clinical trials

Professional Experience

  • Head of the Gastrointestinal Cancer Service Oncology Division of Ichilov Medical Center, Tel Aviv
  • Instructor Faculty of Medicine, Tel Aviv University

Education

  • Ben-Gurion University of the Negev, Israel Faculty of Medicine

Training

  • Board Certification, Clinical Oncology
  • Fellowship 2014 | Royal Marsden Hospital, London, UK

Research

  • Clinical research in gastrointestinal cancers Dr. Peles is involved in clinical research in gastrointestinal cancers.

Publications

Associations

  • Israeli Medical Association
  • Israeli Society of Clinical Oncology and Radiotherapy
  • Member of Helsinki Committee

Book a Consultation

Clinic services are provided privately and via agreements with HMOs and insurers. The TAMC team is available for any request and committed to top-level care.

Frequently Asked Questions

What types of gastrointestinal cancers do you treat most often?

In my daily practice, I most often see patients with colorectal cancer, pancreatic cancer, and gastric cancer. These are probably the most common diagnoses I deal with.

But honestly, it’s rarely straightforward. Some patients come right after diagnosis, others after surgery, and quite a few come after they’ve already received treatment somewhere else.

So the first thing I usually do is slow down and review everything carefully. Imaging, pathology, previous treatments — sometimes small details can change the whole picture. And surprisingly often, we do find additional options that weren’t discussed before.

When should a patient consult a GI oncologist?

I usually tell patients — the earlier, the better. Even if you’re just diagnosed, an early consultation helps clarify the direction and avoid unnecessary delays.

But in reality, many people come later. Sometimes treatment stops working. Sometimes side effects become difficult. Sometimes patients just want another perspective. All of that is completely reasonable.

In oncology, it’s not unusual to reassess the plan along the way. And honestly, that’s often when we can still make meaningful adjustments.

What modern treatment options are available today?

We have several treatment options, including chemotherapy, immunotherapy, and targeted therapy. But they are not interchangeable, and not every treatment is suitable for every gastrointestinal cancer.
I look at the exact diagnosis, the tumor’s biology, the stage of the disease, and any treatment the patient has already received. These details help us decide which approach makes sense.
Sometimes we use a combination of treatments. In other situations, I may consider a clinical trial. The aim is to choose a treatment that fits the patient’s situation.

Do you work with complex or advanced cases?

Yes — very often. A large part of my practice involves patients with advanced disease or after multiple lines of treatment.

These cases require a careful and thoughtful approach. I usually go through the entire history — what was tried, what worked, what didn’t.

Sometimes new options become available over time. Sometimes the situation changes in a way that allows us to consider something different. So even in complex cases, there are often still things we can explore.

Is it possible to get a second opinion?

Yes, absolutely. Some patients come after a new diagnosis, while others have already started treatment and want to review their options.
I usually begin by going through the imaging, pathology reports, and previous treatment summaries. I want to understand why the current plan was chosen and whether there are other options worth discussing.
A second opinion does not always mean changing treatment. Sometimes the review supports the existing plan. In other cases, we may identify an additional option. Either way, the consultation should help the patient understand the next step more clearly.

What should patients prepare before consultation?

If possible, I usually ask patients to send:

Imaging studies
• Pathology reports
• Medical summaries
• Blood tests
But if some documents are missing, we can still begin. The most important step is to start the discussion.

Patient Reviews (0)

No reviews yet

Videos with the Doctor